News

Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy, Study Finds

Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy, Study Finds

August 24, 2016

Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UC San Francisco researcher.

Frequency of Breast Cancer Screening is Best Guided by Both Risk, Breast Density, Says Study

Frequency of Breast Cancer Screening is Best Guided by Both Risk, Breast Density, Says Study

August 22, 2016

The ideal interval for breast cancer screening depends on combined assessments of each woman’s breast cancer risk and her breast density, according to a new study led by UC San Francisco and University of Wisconsin (UW) researchers. The research team, members of two nationwide breast ...
Clearing the Air on E-cigarettes: Q&A with Dr. Stanton Glantz

Clearing the Air on E-cigarettes: Q&A with Dr. Stanton Glantz

August 19, 2016

The FDA earlier this month began banning the sale of electronic nicotine devices (ENDs), also called e-cigarettes, to people younger than 18. The new rules also require a photo ID to purchase tobacco products, prohibit free samples, and selling tobacco products in vending machines.

Immune-Cell Population Predicts Immunotherapy Response in Melanoma

Immune-Cell Population Predicts Immunotherapy Response in Melanoma

August 15, 2016

The abundance of a subtype of white blood cells in melanoma tumors can predict whether or not patients will respond to a form of cancer immunotherapy known as checkpoint blockade, according to a new study led by UC San Francisco researchers and physicians.
UCSF Medical Center Ranked 7th Best Hospital in the U.S. for 2016-17

UCSF Medical Center Ranked 7th Best Hospital in the U.S. for 2016-17

August 2, 2016

UCSF Medical Center has been named among the nation’s premier medical institutions for the 15thconsecutive year, ranking as the seventh best hospital in the country in U.S. News & World Report’s 2016-2017 Best Hospitals survey. UCSF received elite Honor Roll status for exceptional performance in 15 ...
One Minute of Second-Hand Marijuana Smoke Impairs Cardiovascular Function

One Minute of Second-Hand Marijuana Smoke Impairs Cardiovascular Function

July 27, 2016

One minute of exposure to second-hand smoke (SHS) from marijuana diminishes blood vessel function to the same extent as tobacco, but the harmful cardiovascular effects last three times longer, according to a new study in rats led by UC San Francisco researchers.

UCSF Selects Architects for Precision Cancer Medicine Building

UCSF Selects Architects for Precision Cancer Medicine Building

July 21, 2016

UC San Francisco has selected international architecture firm Stantec Inc. to design its new, state-of-the-art Precision Cancer Medicine Building (PCMB) to integrate research and world-class patient care on the UCSF Mission Bay campus.

Childhood Cancer Hijacks Cellular Quality Control System to Fuel Growth

Childhood Cancer Hijacks Cellular Quality Control System to Fuel Growth

July 19, 2016

A serious childhood cancer takes advantage of a quality control mechanism that usually protects cells from stress-induced damage to propel tumor growth, according to a new study led by researchers at UC San Francisco and the University of Pittsburgh. By blocking that mechanism, the scientists ...
Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer

Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer

July 14, 2016

Using advanced imaging technology that allowed them to spy on interactions among cells in the lymph nodes of living mice, a research team led by UCSF scientists has identified a cell that is a key player in mounting the immune system’s defense against cancer. The ...
Covert Inflammation May Trigger Many Forms of Cancer

Covert Inflammation May Trigger Many Forms of Cancer

July 7, 2016

A previously unidentifiable type of low-grade inflammation may explain why common anti-inflammatory drugs such as aspirin have shown promise against some types of cancer – even when patients don’t display typical signs of inflammation.